Tumour necrosis factor signal transduction.
Krönke
M
M
Klinische Arbeitsgruppe, Max-Planck-Gesellschaft, Göttingen, F.R.G.
Schütze
S
S
Scheurich
P
P
Meichle
A
A
Hensel
G
G
Thoma
B
B
Kruppa
G
G
Pfizenmaier
K
K
D000818:Animals; D002460:Cell Line; D002463:Cell Membrane Permeability; D000242:Cyclic AMP / Q000502:physiology; D004790:Enzyme Induction; D005786:Gene Expression Regulation / Q000187:drug effects; D006801:Humans; D008560:Membrane Fluidity; D009928:Organ Specificity; D010740:Phospholipases / Q000378:metabolism; D010766:Phosphorylation; D011494:Protein Kinases / Q000502:physiology; D011499:Protein Processing, Post-Translational; D011956:Receptors, Cell Surface / Q000378:metabolism; D018124:Receptors, Tumor Necrosis Factor; D015398:Signal Transduction; D014157:Transcription Factors / Q000378:metabolism; D014409:Tumor Necrosis Factor-alpha / Q000494:pharmacology / Q000502:physiology*
D011956:Receptors, Cell Surface; D018124:Receptors, Tumor Necrosis Factor; D014157:Transcription Factors; D014409:Tumor Necrosis Factor-alpha; D000242:Cyclic AMP; D011494:Protein Kinases; D010740:Phospholipases